Atopic dermatitis disease biomarkers strongly correlate with IL-13 levels, are regulated by IL-13, and are modulated by tralokinumab in vitro. J of Skin [Internet]. 2019 Nov. 9 [cited 2025 Apr. 19];3:S42. Available from: https://skin.dermsquared.com/skin/article/view/770